PK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid Arthritis
Clinical trial NCT02819726 · COMPLETED
Trial details
- NCT number
- NCT02819726
- Sponsor
- Archigen Biotech Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-11
- Primary completion
- 2018-04-30
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.